
Official twitter account of the European Heart Journal Editor-in-Chief. Tweets by Prof. Filippo Crea and his team. #EHJ.
Rome, Italy
Joined January 2020
- Tweets3.9K
- Following639
- Followers40.9K
- Likes711
Left ventricular outflow tract obstruction in transcatheter mitral interventions: percutaneous anterior leaflet modification. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter #LVOTO #HeartValveDisease #MitralValve @ESC_Journals @ESCardioNews
1
187
Cellular and molecular imaging of coronary atherosclerosis: clinical applications. Read more in EHJ.
doi.org/10.1093/eurheartj/eh…
#CoronaryAtherosclerosis #CardiologyResearch #EHJ @escardio @ESC_Journals
Sex-specific mortality in ischaemic heart disease across Western Europe: 2023 Global Burden of Disease. Read more in EHJ.
doi.org/10.1093/eurheartj/eh…
#IschaemicHeartDisease #SexSpecificHealth #CardiovascularMortality @escardio @ESC_Journals
EHJ issue 47 - 43 is online:
academic.oup.com/eurheartj/i…
Learn about the role of cardiovascular imaging in understanding the mechanisms of cardiovascular disease and its application in everyday clinical practice.
@escardio @ESC_Journals #EHJ #cardiotwitter
Innovation needs industry. Trust needs integrity. A must-read on building collaborations between academia and medtech/pharma that patients can believe in. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
EHJ issue 47 - 42 is online:
academic.oup.com/eurheartj/i…
Explore practice-changing trials, with a focus on prevention, heart failure, interventional cardiology, and rehabilitation.
@escardio @ESC_Journals #EHJ #cardiotwitter
Can a simple ECG spot dilated cardiomyopathy before it shows up? AI-enhanced ECG for detection and prediction of dilated cardiomyopathy: a cheap, scalable tool for earlier diagnosis. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#AI #cardiomyopathy #cardiotwitter @ESC_Journals @escardio
Is “moderate drinking is good for the heart” still true? New review on alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction and accelerated cardiovascular ageing. Time to rethink the glass. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
In hypertrophic cardiomyopathy genetics, “negative” has an expiry date. Updated panels uncover new answers, from ALPK3 and FHOD3 to deep intronic MYBPC3. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiomyopathy #cardiotwitter @ESC_Journals @escardio
Childhood cancer survivors face a hidden late threat: radiation-induced heart disease. Could sacubitril/valsartan help protect the young heart? New preclinical and clinical findings point the way. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#radiation #oncology #cardiotwitter @ESC_Journals @escardio
A simple blood count may reveal hidden plaque. In Progression of Early Subclinical Atherosclerosis, inflammation fuelled early atherosclerosis beyond LDL and blood pressure. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#inflammation #cardiotwitter @ESC_Journals @escardio
Chest pain in the Emergency Department: is it the aorta?
New acute aortic syndrome rule-out criteria, developed and externally validated, to safely skip CT in low-risk patients. Fewer missed dissections, fewer unnecessary scans. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#aorta #emergency #cardiotwitter @ESC_Journals @escardio
Older donor hearts are now the norm in Europe. Should every donor >40 get a coronary angiogram? New Eurotransplant data on how donor angiography shapes organ acceptance and recipient outcomes. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @ESCardioNews
LVOT obstruction: the silent killer of transcatheter mitral replacement
From LAMPOON to BATMAN, percutaneous anterior leaflet modification is turning “screen failures” into treatable patients. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @ESCardioNews
Can an old vasodilator still earn a place in modern HFrEF therapy?
H-HeFT says not yet: neutral primary endpoint, poor tolerability.
But the mortality signal in the meta-analysis won’t go away. Time for a dedicated RCT? Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
Genotype and Arrhythmogenic Risk in Dilated Cardiomyopathy and Arrhythmogenic Cardiomyopathy: Read the news in #EHJ!
ow.ly/IBQK5104fZi
#malignant #ventricular #arrythmias #dilated #cardiomyopathy #cardiotwitter #EHJ @ESC_Journals @escardio
EHJ issue 47 - 41 is online:
academic.oup.com/eurheartj/i…
Delving into acute cardiovascular care: management of delirium, palliative care, cardiogenic shock, Takotsubo syndrome and fulminant myocarditis.
@escardio @ESC_Journals #EHJ #cardiotwitter
The Role of Long-acting glucagon-like peptide-1 receptor agonists in Heart Failure with Preserved Ejection Fraction: Weight Loss-Dependent and Independent Effects!
ow.ly/r0E35104fHV
#EHJ #incretin #therapy #heart #failure #cardiotwitter @ESC_Journals @escardio
Assessing Cardiovascular Risk Through Pregnancy History: Insights on Adverse Outcomes and Long-Term Implications!
ow.ly/hKhw5104fAM
#adverse #pregnancy #outcome #cardiovascular #disease #EHJ #cardiotwitter @ESC_Journals @escardio
Assessing the Dual Biomarker Strategy in Acute Coronary Syndrome: Key Arguments from the Great Debate in #EHJ!
ow.ly/PE4K5103tGw
#copeptin #troponin #Acute #Coronary #Syndrome #triage #emergency @ESC_Journals @escardio















